HopeStage
Back to all studies
RecruitingNCT07362082

RecoveryPad telehealth care for opioid use disorder

About this titleRead the official source — NCT07362082
Device studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

What will I do during this study?

Adults with moderate or severe opioid use disorder may be eligible for this randomized study in Connecticut. Participants are assigned to RecoveryPad, a telehealth platform, or treatment as usual, which includes referrals to harm-reduction and community resources. Eligibility requires English and access to a phone or web-enabled device. The registry excludes people currently taking medication for opioid use disorder, among others; do not stop or change prescribed treatment based on this summary. The study will assess the platform; its benefit is not established.

Listed locations
New HavenSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 11, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
470
Sponsor
Yale University
Sponsor type
University
Study type
Device
Intervention type
Device
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT07362082
Official title
Show the full official title

A Randomized Clinical Trial of Telehealth Treatment for Opioid Use Disorders

Recruitment & locations

Currently recruiting

New Haven

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies